Delivery Order SPE2DB25D3001-SPE2DB25FQUKL
- Not listed
- The Defense Logistics Agency awarded a $128,940 firm fixed price delivery order to Amerisourcebergen Drug Corporation for 4561531051 Urea 40% Cream 85gm. As the prime contractor, Amerisourcebergen will provide the specified pharmaceutical product to DLA, the logistics and procurement agency of the Department of Defense, from its facility in Conshohocken, Pennsylvania. The single order is for delivery between July 18-19, 2023 with no additional subcontractors involved. DLA routinely issues...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,381.02 to AmerisourceBergen Drug Corp for the supply of Opzelura 1.5% Cream in a 60-gram quantity. This competitively awarded, firm fixed-price delivery order was issued on October 22, 2025, with an ultimate completion date of October 23, 2025. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's existing Indefinite Delivery...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order contract by the Defense Logistics Agency on August 5, 2025, for the supply of Opzelura 1.5% Cream in 60-gram quantities. The contract is valued at $14,900.19 and carries a firm fixed price structure with no set-aside designation, indicating it was awarded through open competitive procurement. Performance will be completed by August 6, 2025, with work performed...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $31,651.86 to AmerisourceBergen Drug Corp on June 23, 2025, with an ultimate completion date of June 24, 2025. This firm fixed-price, non-set-aside contract represents a child delivery order issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $1 billion through December 2026. The delivery order will be fulfilled from the vendor's Corporate...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $490,437.70 to AmerisourceBergen Drug Corp on August 14, 2025, with an ultimate completion date of August 15, 2025. This firm fixed-price, non-set-aside contract is a child order under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999.99 million through December 2026. The delivery order will be performed at AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $45,474.95 to AmerisourceBergen Drug Corp on October 30, 2025, for pharmaceutical products and medical supplies under a firm fixed price contract. This non-competitive delivery order, with an ultimate completion date of October 31, 2025, will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider,...
- The U.S. Defense Logistics Agency's Medical Supply Chain awarded a delivery order valued at $119,950.23 to AmerisourceBergen Drug Corp on September 18, 2025, with completion targeted for the same date. This firm fixed-price, competitively awarded delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $1 billion pharmaceutical support vehicle extending through December 2026. The delivery order will be...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $5,575.92 to AmerisourceBergen Drug Corp on July 18, 2025, with an ultimate completion date of July 21, 2025. This firm fixed price, competitively awarded delivery order was issued under a non-set-aside procurement to the pharmaceutical distributor's Corporate Office division, based in Conshohocken, Pennsylvania. The delivery order represents a child contract action under AmerisourceBergen's broader...
- The U.S. Defense Logistics Agency Medical Supply Chain awarded a delivery order valued at $43,377.81 to AmerisourceBergen Drug Corp on August 18, 2025, with completion expected by August 19, 2025. This firm fixed-price, competitively awarded delivery order was issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $1 billion and extends through December 2026. The delivery order represents a child contract...
- The Defense Logistics Agency (DLA) Medical Supply Chain awarded a delivery order valued at $17,139.14 to AmerisourceBergen Drug Corp on April 22, 2025, with completion scheduled for April 23, 2025. This firm fixed price, non-set-aside delivery order represents a child contract action under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The delivery order will be performed at...
- SPE2DB25D3001Indefinite Delivery Contract
- SPE2DB25D3001-SPE2DB25FQUKLDelivery Order
The Defense Logistics Agency (DLA) awarded a delivery order valued at $1,075.53 to AmerisourceBergen Drug Corp for the supply of Urea 40% Cream in a 198.4-gram size. This is a firm fixed price, non-set-aside delivery order with an ultimate completion date of April 23, 2025, issued the day prior on April 22, 2025. The product will be delivered to Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which carries a one billion dollar ceiling and extends through December 2026. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems. The company's substantial IDC vehicle enables it to supply a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, and other critical medical commodities to support military healthcare programs globally. The firm has consistently demonstrated its capability to meet federal procurement requirements through competitive awards, positioning it as a key provider within the DLA's pharmaceutical supply chain infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.1k | 4/22/25 |